期刊文献+

心肌肥厚形成过程中肌醇磷脂途径的作用 被引量:1

Role of phosphoinositide pathway in the formation of cardiac hypertrophy induced by pressure overload in rats
下载PDF
导出
摘要 目的 :探讨肌醇磷脂途径在压力超负荷性心肌肥厚形成中的作用。方法 :对SD大鼠行腹主动脉部分缩窄术复制心肌肥厚模型 ,术后 1 0d、30d时处死动物测全心重 /体重比值 ,以免疫印迹法测左室组织Gαq/ 1 1蛋白含量 ,以放免法测左室组织 1 ,4,5 -三磷酸肌醇 (IP3)含量。结果 :术后 1 0d和 30d时腹主动脉部分缩窄 (CA)组全心重 /体重比值均高于假手术 (SO)组 (P <0 0 1 ) ,在术后 1 0d和 30d两个时点两组大鼠左室组织Gαq/ 1 1蛋白含量均无显著差异 (P >0 0 5)。术后 1 0d时CA组大鼠左室组织IP3含量明显高于SO组 (P <0 0 5) ,但术后 30d时两组IP3含量无显著差异 (P >0 0 5)。结论 AIM: To investigate the role of phosphoinositide pathway in the formation of pressure-overload cardiac hypertrophy. METHODS: Cardiac hypertrophy was induced in male Sprague-Dawley rats with coarctation of abdominal aorta, whole heart weight/body weight ratio was tested after 10 or 30 days of operation. Content of Gαq/11 protein in left ventricle was detected by immunoblot analysis and concentration of IP 3 was measured by radioimmunoassay. RESULTS: At 10 and 30 days, whole heart weight/body weight ratio of coarctation aorta (CA) group was higher than that of sham-operated (SO) rats ( P< 0.01). Protein Gαq/11 contents were not modified after 10 or 30 days of stenosis ( P> 0.05). At 10 days, the level of IP 3 significantly increased in left ventricle of CA rats compared with the control animals ( P< 0.05), but there was no difference in IP 3 level between CA and SO group after 30 days of operation. CONCLUSION: Phosphoinositide signaling pathway may play a role in the early stage of cardiac hypererophy induced by pressure overload.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2002年第8期900-902,共3页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目 (No .39670 31 4 )
关键词 心肌肥厚 信号传递 肌醇1 4 5-三磷酸 发病机制 免疫印迹法 放射免疫法 Hypertrophy,left ventricular Signal transduction Inositol 1,4,5-triphosphate
  • 相关文献

参考文献7

  • 1[1]Hefti MA, Harder BA, Eppenberger HM, et al. Signaling pathways in cardiac myocyte hypertrophy[J]. J Mol Cell Cardiol, 1997,29(11):2873-2892.
  • 2[2]De Jonge HW, Van Heugten HAA, Lamers JMJ. Signal transduction by the phosphatidylinositol cycle in myocardium[J]. J Mol Cell Cardiol, 1995,27(1): 93-106.
  • 3[3]Sahlgren B, Eklof AC, Aperia A. Studies of the renal component of the hypertension in rats with aortic constriction: role of angiotensin Ⅱ[J]. Acta Physiol Scand, 1986,127(4): 443-448.
  • 4[4]Gettys TW, Sheriff Carter K, Moomaw J, et al. Characterization and use of crude α-subunit preparations for quantitative inmunoblotting of G proteins[J].Anal Biochem, 1994,220(1):82-91.
  • 5[5]Li P, Zou AP, Al-kayed NJ, et al. Guanine nucleotide-binding proteins in aortic smooth muscle from hypertensive rats[J]. Hypertension, 1994,23[6 part 2]:914-918.
  • 6[6]Lamorte VJ, Thorburn J, Absher D, et al. Gq and ras dependent pathways mediated hypertrophy of neonatal rat ventricular myocytes following α1, adrenergic stimulation[J]. J Biol Chem, 1994,269(18):13490-13496.
  • 7[7]Sadoshima JI, Izumo S. Signal transduction pathways of angiotensin Ⅱ induced c-fos gene expression in cardiac myocytes in vitro[J]. Circ Res, 1993, 73(3):424-438.

同被引文献9

  • 1Pfetfer JM, Pfetfer MA, Mirsky I, et al. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in spontaneously hypertensive rats[J].Proc Natl Acad Sci USA, 1982,79(10) :3310 - 3314.
  • 2Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive theraphy[ J ]. Cardiovasc Res, 1977, 11 (5) :427 - 433.
  • 3van Zwieten PA. Renewed interest in centrally acting antihypertensive drugs[J]. Cardiovasc J S Afr, 2000 , 11(4):225- 229.
  • 4Messerli F. Moxonidine: a new and versatile antihypertensive[J]. J Cardiovasc Pharmacol, 2000,35(7 suppl 4):S53 -S56.
  • 5Weber KT, Janicki JS, shroff SG, et al. Collagen remodeling of pressure overoad, hypertrophied nonhuman primate myocardium[J].Circ Res, 1988,62(4) :757 -765.
  • 6Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy[J]. Circulation, 1991,83(5): 1717 - 1729.
  • 7Mitrovic V, Hamel M, Miric M, et al. Effect of the imidazoline receptor agonist moxonidine on hemodynamics, coronary circulation, metabolic ischemia markers and neurohumoral system in patients with essential hypertention: effects of moxonidine on coronary circulation[J]. Z Kardiol, 2001, 90(12):953 - 963.
  • 8Mall G, Greber D, Gharehbughi H, et al. Effect of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats- stereological studies on myoeytes, capillaries, arteries, and cardiac interstitium[J]. Basic Res Cardiac, 1991,86(suppl 3) :33 - 44.
  • 9Brilla CG, Janiki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries[J]. Cire Res, 1991,69( 1 ) : 107 - 115.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部